Anemia is common in patients with chronic kidney diseases (CKD). It a complication of advanced CKD. Its prevalence CKD stage 5 populations over 50%. The hormone “erythropoetin” (EPO) secreted by the kidneys essential maintenance adequate hemoglobin human body. Scientific Presentation BJM Vol. 34 No. 2(1) Suppliment 2023 177 Apart from failure EPO secretion, many other factors including inflamma...

Background: Admitted patients with anemia are at increased morbidity and mortality risk, as well length of hospital stay. It affects more than 2 billion people worldwide is causing significant mortality. Its etiology variable, many predisposing factors including nutritional deficiencies, infections, malignancies, chronic inflammations, other diseases like autoimmune diseases, liver disease, kid...

Anemia is one of the most characteristic and visable manifestations of chronic renal failure. Investigators in the past decade have provided a better understanding of this anemia. The etiology of the anemia of chronic renal failure has three facets: first is reduced erythropoietin production by damaged kidneys; second is the presence of inhibitors to red blood cell (RBC) production in uremic se...

Background Anemia is a common complication of chronic kidney disease. There are various causes of anemia in chronic kidney disease patients on hemodialysis. Secondary hyperparathyroidism is one of the less recognized causes of anemia in chronic kidney disease patients. Objectives The main objective of the study is to find the correlation between intact parathyroid hormone and hematocrit level i...

A UTOIMMUNE HEMOLYTIC ANEMIA may complicate a wide variety of diseases, among which are infectious diseases, “collagen” diseases, benign tumors, malignant tumors, lymphomas and Hodgkin’s disease.1’2 The lymphoproliferative disorders, especially chronic lymphatic leukemia, have often been associated with abnormal immunologic mechanisms. The myeloproliferative disorders are rarely associated with...

Macrocytic anemia is found in many persons with chronic hepatic disease. The incidence recorded by different observers had varied from 18% to 89%. Observations reported by Wintrobe (1) set the incidence of macrocytosis at 40.9%o in 44 persons with cirrhosis and 62.5% in eight persons with cirrhosis and malignant disease of the liver. However, the pathogenesis of the anemia has not been clearly ...

Background: Chronic kidney disease (CKD), also known as chronic renal disease, is progressive loss in function over a period of months or years. It an internationally recognized public health problem affecting 5–10% the world population. Objective: To evaluate role reticulocyte hemoglobin content and soluble transferrin receptor concentration for detection iron deficiency anemia Egyptian patien...

Background: Cardiorenal syndrome (CRS) in patients with end-stage kidney disease (ESKD) represents mainly cardiovascular disease (CVD) due to various complications associated with renal dysfunction—defined as type 4 CRS by Ronco et al.—because the effect of cardiac dysfunction on the kidneys does not need to be taken into consideration, unlike in non-dialysis dependent chronic kidney disease (C...